Nurse Practitioner · Atlanta, GA
NPI
1164566253
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
275 Collier Rd NW, Suite 500
Atlanta, GA, 30309
Phone (404) 605-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
189,405 services
Medicare patients, 2024
785
Average age 75
Drug cost, 2024
$4.4M
5,402 prescriptions
Company payments, 2025
$26K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Janice McAlister was code J1306 (injection, inclisiran, 1 mg), 186,588 times for 357 patients. In total Janice McAlister billed 189,405 services in 12 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 186,588 | 357 | $9.45 | $1.8M |
| 99214 Office E&M - Established | Office | 1,103 | 723 | $81.41 | $90K |
| 36415 Venipuncture Blood Collection | Office | 890 | 607 | $8.65 | $7,699 |
| 96372 Injection Administration | Office | 658 | 357 | $9.74 | $6,409 |
| 99213 Office E&M - Established | Office | 71 | 65 | $53.79 | $3,819 |
| 99212 Office E&M - Established | Office | 67 | 66 | $38.52 | $2,581 |
| 99204 Office E&M - New | Office | 12 | 12 | $88.87 | $1,066 |
| 99203 Office E&M - New | Office | 12 | 12 | $63.35 | $760 |
By year: 2022 $623K for 54,921 services; 2023 $1.6M for 157,624 services; 2024 $1.9M for 189,405 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 890 | 607 | $8.65 | $7,699 |
Medicare prescription drug claims, 2024
In 2024, the drug Janice McAlister prescribed most often to Medicare patients was Repatha Sureclick (Evolocumab), with 1,881 prescriptions and refills. In total Janice McAlister wrote 5,402 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repatha Sureclick Evolocumab | 1,881 | 4,344 | 473 | $2.5M |
| Ezetimibe Generic | 813 | 2,328 | 271 | $19K |
| Rosuvastatin Calcium Generic | 480 | 1,355 | 166 | $5,439 |
| Praluent Pen Alirocumab | 358 | 856 | 97 | $446K |
| Atorvastatin Calcium Generic | 270 | 757 | 82 | $2,700 |
| Nexletol Bempedoic Acid | 146 | 196 | 26 | $78K |
| Amlodipine Besylate Generic | 115 | 345 | 45 | $662 |
| Losartan Potassium Generic | 96 | 288 | 37 | $756 |
| Metoprolol Succinate Generic | 92 | 244 | 28 | $806 |
| Lisinopril Generic | 89 | 253 | 29 | $682 |
| Nexlizet Bempedoic Acid/Ezetimibe | 89 | 145 | 18 | $58K |
| Vascepa Icosapent Ethyl | 80 | 150 | 17 | $50K |
| Metoprolol Tartrate Generic | 57 | 165 | 16 | $275 |
| Clopidogrel Clopidogrel Bisulfate | 48 | 144 | 14 | $575 |
| Hydrochlorothiazide Generic | 40 | 118 | 16 | $127 |
Brand drugs: 2,676 claims; generic drugs: 2,726 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Janice McAlister $26K ($26K in general payments such as food, travel and fees) from 9 companies. The largest payer was Amgen Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 50 | $21K |
| Merck Sharp & Dohme LLC MRK | 10 | $4,061 |
| Novartis Pharmaceuticals Corporation NVS | 31 | $646 |
| Chiesi USA, Inc. | 3 | $606 |
| Heartflow, Inc. HTFL | 1 | $124 |
| Esperion Therapeutics, Inc. ESPR | 3 | $78.51 |
| Pfizer Inc. PFE | 3 | $55.12 |
| Novo Nordisk Inc NVO | 2 | $35.47 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $22.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.